QT Imaging Completes 1st In Class and 1st In Human Study: Quantitative Transmission Ultrasound Research Shows Better Performance than Mammography
CEO and Chief Medical Officer Dr. John Klock advises, "This research represents an important milestone because it's the first time a novel technology was compared to the standard of care in breast imaging in a primary breast cancer screening setting.
IceCure Medical Achieves Signed Distribution Agreement on with Terumo Corporation for Thailand on December 28, 2020: Cryoablation Products to Benefit More Patients in Asia
The expanded partnership reflects the ongoing success of the initial agreement, which was signed in September 2019, and included distribution rights in Japan and Singapore.
Exact Sciences Completes Acquisition of Thrive Earlier Detection: Blood-Based Multi-Cancer Screening Becomes a Reality & Eventually the Standard of Care Notes CEO
Chairman and CEO Kevin Conroy said, "Bringing Thrive into the Exact Sciences family marks a giant leap toward blood-based, multi-cancer screening becoming a reality and eventually the standard of care.
Emboline Raises Over $10 Million in Series C Funding: Funds Raised To Be Used to Obtain Initial Commercial Approval of the Emboliner & Launch...
xEmboline recently completed the 3-center, 31-patient SafePass 2 study of the Emboliner™ in New Zealand in which the device met all primary endpoints for safety and technical performance when used during TAVR.
George Farmer, Ph.D., Appointed Chief Financial Officer at PureTech: Experienced Financial Analyst & Biotech Executive Complements the Team
Dr. Farmer will be responsible for all aspects of the Company’s finances, including capital markets strategy and execution, strategic and financial planning, and financial reporting.